These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 3966738
1. Levamisole, immunostimulation, and the acquired immunodeficiency syndrome. Surapaneni N, Raghunathan R, Beall GN, Daniel K, Mundy TM. Ann Intern Med; 1985 Jan; 102(1):137. PubMed ID: 3966738 [No Abstract] [Full Text] [Related]
4. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug]. Giulling EV, Kravchuk GP, Kazirchuk VE, Maksiuk LV, Zabolotnyĭ DI. Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615 [No Abstract] [Full Text] [Related]
15. [Levamisole in the treatment of nephrotic syndrome]. García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P. An Pediatr (Engl Ed); 2020 Mar; 92(3):168-169. PubMed ID: 31151760 [No Abstract] [Full Text] [Related]
17. Is there a contraindication for polio vaccination in children who are treated with levamisole? Blanche S. Pediatr Nephrol; 2000 Sep; 14(10-11):1059. PubMed ID: 10975326 [No Abstract] [Full Text] [Related]
18. Levamisole as an immunostimulant. Pár A. Ther Hung; 1980 Sep; 28(4):163-7. PubMed ID: 6782693 [No Abstract] [Full Text] [Related]
19. Levamisole: A multi-faceted drug in dermatology. Gupta M. Indian J Dermatol Venereol Leprol; 2016 Sep; 82(2):230-6. PubMed ID: 26924410 [No Abstract] [Full Text] [Related]
20. Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial. Zhang H, Shan C, Hua Z, Zhao P, Zhang H. J Int Med Res; 2009 Sep; 37(4):1167-72. PubMed ID: 19761700 [Abstract] [Full Text] [Related] Page: [Next] [New Search]